22 /100
LOW RISK
Score updated Jul 13, 2026

MXCT — MaxCyte, Inc. Dilution Risk Tracker

Track MXCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MXCT — Get alerts when the score changes →

As of July 13, 2026, MaxCyte, Inc. (MXCT) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. MaxCyte, Inc. has a market capitalization of $129.62M, 107.12M shares outstanding, 131 institutional holders tracked. Key dilution vectors include 71.2K outstanding warrants, approximately 34 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
5
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.87 below $1 exchange minimum
🔔 Track MXCT — Get forecast alerts →

💹 Market Data

Market Cap$129.62M
Shares Outstanding107.12M
Float97.67M
Cash$106.85M
Debt$17.49M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 15.2% shares (2026Q1 vs prior)
131 institutional holders · 82.71M shares
#1 MORGAN STANLEY 14.82M shares
#2 BlackRock, Inc. 8.80M shares
#3 Capricorn Fund Managers Ltd 8.20M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.52M
Days to Cover1.0
% of Float1.6%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MXCT Shareholders

MaxCyte, Inc. (MXCT) has a DilutionScore of 22/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MXCT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MXCT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MXCT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MXCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MXCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MXCT
📊 MXCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MXCT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.